Category: Cardiac Rhythm ManagementSyndicate content

AliveCor lands FDA win for at-home afib diagnosis

August 21, 2014 by Arezu Sarvestani

FDA regulators grant AliveCor new clearance for an at-home heart rhythm test for diagnosing asymptomatic atrial fibrillation.

AliveCor lands FDA win for at-home afib diagnosis

AliveCor hit a major turning point for its smartphone-based ECG technology with FDA clearance for a new algorithm that helps patients diagnose their own heart rhythms.

Biotronik study: Remote heart monitoring helps save lives

August 19, 2014 by Arezu Sarvestani

Researchers report that patients with heart failure that were monitored from afar via fared better than those that received traditional follow-up care.

Study: Remote defib monitoring helps save lives

Home-based heart monitoring could help save lives while reducing the cost of follow-up care for patients with heart failure, according to a new study.

Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit

August 18, 2014 by Brad Perriello

Mirowski Family Ventures asks the U.S. Supreme Court to hear its appeal in a patent infringement lawsuit against Medtronic.

Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit

Study: Afib doubles stroke risk after surgery

August 13, 2014 by Arezu Sarvestani

Surgical patients who experience atrial fibrillation may see a doubled stroke risk in the months following their procedure, according to a new study published in JAMA.

Study: Post-surgery afib heightens lifetime stroke risk

Results from a new study suggest that atrial fibrillation (AF) may pose a significant threat to patients undergoing surgery, especially those having non-cardiac procedures.

In an analysis of more than 1.7 million patients, researchers found that perioperative AF was associated with twice the risk of stroke in patients who had non-cardiac surgery. Patients who underwent a cardiac procedure saw a 30% increase in their stroke risk.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic brings new smart pacemaker to India | On Call

August 8, 2014 by Arezu Sarvestani

Medtech titan Medtronic launched a new cardiac resynchronization therapy-pacemaker for the Indian market after landing CE Mark approval in the European Union earlier this year. On Call

MASSDEVICE ON CALL — Medtronic (NYSE:MDT) this week announced that it's bringing its Viva cardiac resynchronization therapy-pacemaker to the market in India, a country where Medtronic is banking on significant growth.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp